Respiratory Infections News

Modeling showed that serially testing asymptomatic residents and staff in nursing homes could prevent more than 50% of SARS-CoV-2 infections in an outbreak, according to study results published in Clinical Infectious Diseases.

Up to 32% of people who died with COVID-19 had a bacterial lung superinfection, according to findings from a review of postmortem studies.

Prior to COVID-19, experts frequently warned that it was not a matter of if, but when the world would experience its next pandemic.

A new study will evaluate remdesivir as a COVID-19 treatment in pregnant women, the NIH said.

Although the Biden administration has said that enough COVID-19 vaccine doses will be available in the U.S. to vaccinate 300 million people by the end of July, it is still unclear when vaccines will be widely available to children.

Approximately 30% of patients with COVID-19 enrolled in a study at the University of Washington reported persistent symptoms 3 to 9 months after illness onset, according to results published in JAMA Network Open.

As the pace of the COVID-19 vaccine rollout increases in the U.S., experts continued to reassure the public of the safety and efficacy of available vaccines and their importance in addressing the spread of variants and ending the pandemic.

Temporarily separating mothers with confirmed or suspected COVID-19 from their newborns and disrupting skin-to-skin care, rooming-in and direct breastfeeding was “associated with harm and may be unnecessary,” according to researchers.

On Wednesday, CDC Director Rochelle Walensky, MD, MPH, reported that COVID-19 cases in the United States have declined for 5 consecutive weeks, and new hospitalizations have been consistently down since early January.

Black and Hispanic Medicare beneficiaries were less likely to say they would get a COVID-19 vaccine than white recipients despite being more likely to recognize COVID-19’s increased severity compared with influenza, a survey showed.